NEVVI Medicare utilization intelligence
or

← back

Provider profile

ANDERSON, JADE M.D.

Medical Oncology · NPI 1720098064 · AMARILLO, TX

1
Groups
77
Codes · 2024
125,906
Disclosed services

ANDERSON, JADE is a Medical Oncology in AMARILLO, TX, a member of 1 medical group, who billed 77 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

125,906
disclosed services
77
codes billed to Medicare Part B
Prior year · CY2023 105,132 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J9267 Injection, paclitaxel, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J0461 Injection, atropine sulfate, 0.01 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J0640 Injection, leucovorin calcium, per 50 mg
J3475 Injection, magnesium sulfate, per 500 mg
J9190 Injection, fluorouracil, 500 mg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
80053 Blood test, comprehensive group of blood chemicals
J3480 Injection, potassium chloride, per 2 meq
36415 Insertion of needle into vein for collection of blood sample
96375 Injection of additional new drug or substance into vein
J3489 Injection, zoledronic acid, 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J9045 Injection, carboplatin, 50 mg
96372 Injection of drug or substance under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96417 Administration of additional new drug or substance into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
82728 Ferritin (blood protein) level
83615 Lactate dehydrogenase (enzyme) level
83540 Iron level
J3490 Unclassified drugs
83550 Iron binding capacity
85046 Red blood count automated, with additional calculations
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
84443 Blood test, thyroid stimulating hormone (tsh)
96360 Infusion into a vein for hydration, 31-60 minutes
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
82607 Cyanocobalamin (vitamin b-12) level
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
82784 Gammaglobulin (immune system protein) measurement
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
85055 Reticulated (young) platelet measurement
96361 Infusion into a vein for hydration, each additional hour
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96411 Administration of additional new drug or substance into vein using push technique
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96523 Irrigation of implanted venous access drug delivery device
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96374 Injection of drug or substance into vein
81001 Manual urinalysis test with examination using microscope, automated
82746 Folic acid level, serum
84165 Protein measurement, serum
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99406 Smoking and tobacco use intensive counseling, 4-10 minutes
82270 Stool analysis for blood to screen for colon tumors
85007 Microscopic examination for white blood cells with manual cell count

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.